BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29453859)

  • 1. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
    Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
    Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
    Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
    Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
    Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
    Amft N; Curnow SJ; Scheel-Toellner D; Devadas A; Oates J; Crocker J; Hamburger J; Ainsworth J; Mathews J; Salmon M; Bowman SJ; Buckley CD
    Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome.
    Salomonsson S; Larsson P; Tengnér P; Mellquist E; Hjelmström P; Wahren-Herlenius M
    Scand J Immunol; 2002 Apr; 55(4):336-42. PubMed ID: 11967114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.
    Hansen A; Odendahl M; Reiter K; Jacobi AM; Feist E; Scholze J; Burmester GR; Lipsky PE; Dörner T
    Arthritis Rheum; 2002 Aug; 46(8):2160-71. PubMed ID: 12209521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome.
    Verstappen GM; Meiners PM; Corneth OBJ; Visser A; Arends S; Abdulahad WH; Hendriks RW; Vissink A; Kroese FGM; Bootsma H
    Arthritis Rheumatol; 2017 Sep; 69(9):1850-1861. PubMed ID: 28564491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjögren's syndrome.
    Li XY; Wu ZB; Ding J; Zheng ZH; Li XY; Chen LN; Zhu P
    Biochem Biophys Res Commun; 2012 Jun; 422(2):238-44. PubMed ID: 22575453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviating effect of paeoniflorin-6'-O-benzene sulfonate in antigen-induced experimental Sjögren's syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
    Chen X; Zhang P; Liu Q; Zhang Q; Gu F; Xu S; Körner H; Wu H; Wei W
    Int Immunopharmacol; 2020 Mar; 80():106199. PubMed ID: 31955068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
    Peck AB; Nguyen CQ; Ambrus J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases.
    Aust G; Sittig D; Becherer L; Anderegg U; Schütz A; Lamesch P; Schmücking E
    Eur J Endocrinol; 2004 Feb; 150(2):225-34. PubMed ID: 14763921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis.
    Kramer JM; Klimatcheva E; Rothstein TL
    J Leukoc Biol; 2013 Nov; 94(5):1079-89. PubMed ID: 23904442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
    Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
    Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
    Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
    Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Expression of CXCL13 and Its Chemokine Receptor CXCR5 on B Lymphocytes during Active Graves' Orbitopathy.
    Wan S; Lin M; Mao Y; Chen X; Liang D
    Curr Eye Res; 2021 Feb; 46(2):210-216. PubMed ID: 32643429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL13 as biomarker for histological involvement in Sjögren's syndrome.
    Colafrancesco S; Priori R; Smith CG; Minniti A; Iannizzotto V; Pipi E; Lucchesi D; Pontarini E; Nayar S; Campos J; Arienzo F; Fusconi M; Cerbelli B; Giordano C; Valesini G; Bombardieri M; Fisher BA; Barone F
    Rheumatology (Oxford); 2020 Jan; 59(1):165-170. PubMed ID: 31274159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-Resident Memory CD8+ T Cells Acting as Mediators of Salivary Gland Damage in a Murine Model of Sjögren's Syndrome.
    Gao CY; Yao Y; Li L; Yang SH; Chu H; Tsuneyama K; Li XM; Gershwin ME; Lian ZX
    Arthritis Rheumatol; 2019 Jan; 71(1):121-132. PubMed ID: 30035379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.
    Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.